163 related articles for article (PubMed ID: 3798417)
41. A rapid latex agglutination assay for the determination of plasma fibrinogen.
Gargan PE; Sheehan C; Williams L; Ploplis V; Hearty U; Lowry C
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):465-8. PubMed ID: 2133224
[TBL] [Abstract][Full Text] [Related]
42. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
Horan JT; Francis CW
Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
[TBL] [Abstract][Full Text] [Related]
43. Kinetic latex agglutinometry I. A rapid, quantitative immunologic assay for fibrinogen.
Babson AL; Opper CA; Crane LJ
Am J Clin Pathol; 1982 Apr; 77(4):424-9. PubMed ID: 7072650
[TBL] [Abstract][Full Text] [Related]
44. A clinical evaluation of Thrombo-Wellcotest as a screening test for D.I.C.
Song KS; Ahn YM; Kim HS; Lee SY
Yonsei Med J; 1980; 21(1):58-61. PubMed ID: 7269637
[No Abstract] [Full Text] [Related]
45. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
Lychev VG; Momot AP; Cherkashin GV
Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
[TBL] [Abstract][Full Text] [Related]
46. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
Song KS; Kim YA; Kim HK; Park Q
Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
[TBL] [Abstract][Full Text] [Related]
47. Analytical comparison of AxSYM, HemosIL DD HS and Innovance D-dimer immunoassays with the Vidas D-dimer.
Salvagno GL; Lippi G; Manzato F; Giavarina D; Montagnana M; Poli G; Guidi GC
Int J Lab Hematol; 2009 Aug; 31(4):475-7. PubMed ID: 18503567
[No Abstract] [Full Text] [Related]
48. Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products.
Connaghan DG; Francis CW; Ryan DH; Marder VJ
Am J Clin Pathol; 1986 Sep; 86(3):304-10. PubMed ID: 3751995
[TBL] [Abstract][Full Text] [Related]
49. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
Kawai Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():618-22. PubMed ID: 15658405
[No Abstract] [Full Text] [Related]
50. Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.
Sigal SH; Cembrowski GS; Shattil SJ; Brown NM; Schifreen RS; Schwartz MW
Arch Intern Med; 1987 Oct; 147(10):1790-3. PubMed ID: 3662708
[TBL] [Abstract][Full Text] [Related]
51. A latex agglutination assay for D dimer: evaluation and application to the diagnosis of thrombotic disease.
Hillyard CJ; Blake AS; Wilson K; Rylatt DB; Miles S; Bunch R; Elms MJ; Barnes A; Bundesen PG
Clin Chem; 1987 Oct; 33(10):1837-40. PubMed ID: 3311466
[TBL] [Abstract][Full Text] [Related]
52. Usefulness of a latex agglutination assay for FDP D-dimer to demonstrate the presence of postmortem blood.
Sakurada K; Sakai I; Sekiguchi K; Shiraishi T; Ikegaya H; Yoshida K
Int J Legal Med; 2005 May; 119(3):167-71. PubMed ID: 15654628
[TBL] [Abstract][Full Text] [Related]
53. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
Isogai N; Yamagishi T; Kaku M; Matsumoto K; Yamamoto Y; Kuroso K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
Rinsho Byori; 1991 Jul; 39(7):753-7. PubMed ID: 1920869
[TBL] [Abstract][Full Text] [Related]
54. [Comparison of 2 tests for determining lytic products of fibrin].
Chalini-Carreon F; Ortiz-Méndez VM; Olvera-Hidalgo C; Magaña-Pérez JA
Bol Med Hosp Infant Mex; 1983 Nov; 40(11):613-7. PubMed ID: 6651948
[No Abstract] [Full Text] [Related]
55. [Comparison of results of fibrinogen degradation products (FDP) determination by immunologic methods and the results of other studies of the blood clotting system].
Palester-Chlebowczyk M; Vertun B; Strzyźewska E; Królikiewicz K
Pol Arch Med Wewn; 1977 Sep; 58(3):247-56. PubMed ID: 928163
[No Abstract] [Full Text] [Related]
56. [A specific marker of thrombolysis: DDE complex].
Soria J; Soria C; Mirshahi M; Mirshahi M; Boucheix C; Pujade E; Perrot JY; Samama M; Bernadou A; Caen JP
C R Acad Sci III; 1987; 304(11):307-11. PubMed ID: 3103876
[TBL] [Abstract][Full Text] [Related]
57. A quantitative automated immunoassay for fibrinogen/fibrin degradation products.
Schifreen RS; Cembrowski GS; Campbell DC; Craig AR; Demyanovich ND; Jurga-Hall PA; Reider MC; Schwartz MW; Tuhy PM; Waller SJ
Clin Chem; 1985 Sep; 31(9):1468-73. PubMed ID: 4028396
[TBL] [Abstract][Full Text] [Related]
58. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
59. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states.
Wilde JT; Kitchen S; Kinsey S; Greaves M; Preston FE
Br J Haematol; 1989 Jan; 71(1):65-70. PubMed ID: 2917130
[TBL] [Abstract][Full Text] [Related]
60. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
